GPX4 and acute kidney injury: Specifically, we propose that SAB enhances the activity of the SLC7A11 and GPX4 proteins by binding to peroxiredoxin 5 (PRDX5) and boosting PRDX5's bioactivity in cisplatin‐induced AKI.